Chimeric Antigen Receptor (CAR) T-cell Therapy
Customize your policy alerts
Sign up for Presbyterian Health Plan Policy 32.0 alerts
Get alerted when Policy 32.0 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and prior authorization for CAR T-cell therapy, including collection, preparation, and administration-related services and products. Coverage applies to Commercial, Centennial, and Medicare members, subject to the member's specific benefit plan and Presbyterian's use of Optum CAR T-Cell Therapy Clinical Guidelines.
The 2025 annual review added HCPCS Q2058 and CPT codes 38225, 38226, 38227, and 38228 to the policy.
CPT codes 0537T, 0538T, 0539T, and 0540T became invalid as of January 1, 2025.
The policy criteria were replaced with a direction to use Optum CAR T-Cell Therapy Clinical Guidelines.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.